Boston Scientific Senior HEMA Manager - Global Urology Strategy 

United States, Massachusetts, Marlborough 

380400966

Your responsibilities will include:

Driving Evidence Strategy (D)

• Lead development of a franchise-level evidence and reimbursement strategy for SNM that clearly differentiates product value.
• Identify unmet evidence needs by analyzing payer trends, competitive publications, and stakeholder input, and prioritize initiatives that have the highest business and patient impact.
• Build strategic relationships with Key Opinion Leaders (KOLs) and external experts to co-author publications, validate payer-relevant endpoints, and strengthen credibility with payers and providers.
• Collaborate with Corporate health economics and outcomes research (HEOR) as the executional partner for research studies, ensuring strategic priorities are translated into protocols, payer-relevant endpoints, and publications that support market access and reimbursement.
• Engage with regional HEMA colleagues to ensure alignment of U.S. priorities with international access needs, creating visibility and impact beyond the U.S. market.

Reimbursement Strategy & Analytic Influence (R)

• Partner with the in-house Reimbursement function to design and implement strategic reimbursement initiatives that secure and expand coverage, influence policymakers, shape coding and payment pathways, and strengthen long-term market access for SNM therapies.
• Collaborate with the Analytic HEMA team to set priorities and ensure reimbursement data and insights are generated to inform strategy, while leaving execution of analyses to the analytic experts.
• Ensure analytic outputs are framed and communicated as payer-relevant insights that support coverage decisions, coding/payment strategy, and Boston Scientific’s overall market access objectives.

Enabling Market Access & Field Impact (E)

• Partner with Field HEMA and Sales Leadership to identify payer and provider needs, and translate those insights into tools and messaging that enable successful commercialization of SNM therapies.
• Provide strategic input on field-owned materials (e.g., dossiers, reimbursement guides) to ensure alignment with HEMA evidence and consistent value messaging.
• Partner with the Analytic HEMA team to guide priorities and ensure the development of customer-facing tools and dashboards that equip field and account teams to drive adoption.
• Collaborate with Marketing, National Accounts, and the in-house Reimbursement function to ensure payer-relevant value propositions are consistently reflected across customer-facing channels and engagements.

Activating Evidence Dissemination (A)

• Lead dissemination of HEMA evidence and reimbursement insights to internal and external stakeholders, ensuring key findings are delivered with strategic impact.
• Translate complex analytic and clinical data into clear, compelling value stories tailored for payers, providers, policymakers, and internal leadership.
• Partner with Marketing, Communications, and Clinical teams to expand the reach of SNM evidence through publications, payer forums, medical congresses, digital platforms, and leadership presentations.
• Ensure global and U.S. dissemination strategies are aligned, maximizing visibility and reinforcing Boston Scientific’s value proposition for SNM therapies.

Multi-Functional & Global Partnerships (M)

• Represent HEMA in franchise leadership forums, ensuring evidence and reimbursement perspectives are embedded in portfolio planning, strategic decisions, and commercialization priorities.
• Build strong partnerships across Marketing, Clinical, Sales Leadership, National Accounts, the in-house Reimbursement function, and regional HEMA colleagues to align on access strategy and execution.
• Engage with regional HEMA teams to anticipate international market needs, share U.S. insights, and connect them with resources to advance their HEMA strategies in their regions.
• Elevate the role of HEMA as a business-critical partner by proactively shaping cross-functional discussions and influencing senior stakeholders.

Required qualifications:

• Bachelor’s degree and 8+ yearsof experience in medical device, pharmaceutical, biotech, or consulting with a focus on health economics, outcomes research, reimbursement strategy, market access, or strategic marketing/commercialization.
• Strong market research, HEOR, or data analytics background with the ability to critically evaluate study design, interpret outputs, and guide evidence priorities (execution supported by analytic partners such as Corporate HEOR and Analytic HEMA).
• Demonstrated understanding of the U.S. healthcare reimbursement and policy landscape, with exposure to global payer environments.
• Proven success in partnering with commercial functions (Marketing, Sales Leadership, National Accounts) to integrate evidence and reimbursement insights into commercialization strategies.
• Ability to translate complex analytic and clinical findings into clear, payer-relevant insights and value messaging for payers, providers, policymakers, and executives.
• Strong leadership, collaboration, and communication skills with demonstrated ability to influence senior leadership and cross-functional teams.
• Ability to thrive in a fast-paced, matrixed environment, balancing multiple priorities and building alignment across functions.
• Domestic and limited international travel is estimated at 20%.

Preferred qualifications:

• Advanced degree (Master’s or higher) in health economics, public health, health policy, healthcare administration, health services research, business (MBA), or a related analytics/strategic discipline.

• Experience applying strategic commercial or market access analysis to shape business decisions and guide reimbursement strategy.
• Familiarity with urology, neuromodulation, or related therapeutic areas.
• Demonstrated success in shaping reimbursement or policy strategies that expand patient access.
• Experience representing HEMA in franchise leadership forums, payer/provider engagements, or global collaborations.

Compensation fornon-exempt (hourly), non-sales rolesmay also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements).

Compensation forexempt, non-sales rolesmay also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements).

For MA positions:It is unlawful to require or administer a lie detector test for employment. Violators are subject to criminal penalties and civil liability.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.